Profile
Dr. Alvin Lee is an Associate Consultant Urologist at the Department of Urology, Singapore General Hospital. He obtained his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the Yong Loo Lin School of Medicine, National University of Singapore, in 2015, where he was recognised on the Dean’s List and awarded the Second Mekie Book Prize (second top performing surgery candidate) and Distinction in Surgery.
Throughout his residency training with SingHealth, Dr. Lee was appointed the Chief Resident and was awarded Outstanding Resident Award on multiple occasions. He was awarded the European Board of Urology (EBU) Book Prize by the Singapore Urological Association in 2022 for being the top-scoring candidate. He completed his specialist training and is a Fellow of the Academy of Medicine, Singapore (FAMS), as well as the Royal College of Surgeons of Glasgow (FRCS) (Urology).
Dr. Lee’s subspecialty clinical interests are in uro-oncology and minimally-invasive surgery. Dr. Lee has published extensively on prostate cancer diagnosis (prostate-specific antigen and prostate biopsy), including first-author publications in leading peer-reviewed journals, including British Journal of Urology International and Prostate Cancer and Prostatic Diseases. He was awarded the Singhealth Publish! Award (2021) for his academic achievements.
Dr. Lee is experienced in the diagnosis and treatment of many urological symptoms such as renal colic (flank pain), lower urinary tract symptoms and gross haematuria (blood in the urine) that may be caused by underlying urological conditions such as benign prostate hyperplasia (enlargement), urinary stone disease and cancers of the urinary tract. Dr. Lee's dedication to providing exceptional patient care has been recognised with several awards, including the Singapore Health Quality Service Award (Silver) in 2023, multiple Service with a Heart awards (2022 and 2023) and the Service Excellence Award (2023).
Education
- FRCS (Glasgow) (Urology) 2024
- FAMS (Urol) 2024
- DWD (CAW) 2017
- MRCS (Ireland) 2016
- MBBS (Singapore) 2015
View More +
Professional Appointments and Committee Memberships
View More +
Awards
- Outstanding Resident Award (AY2023/2024)
- Outstanding Resident Award (AY2022/2023)
- Antibiotic Champion (awarded by Antimicrobial Stewardship Unit, SGH) (2023)
- Singapore Health Quality Service Award (Silver) (2023)
- Service Excellence Award (Jan – May 2023)
- Service with a Heart Award (2023)
- Service with a Heart Award (2022)
- EBU Book Prize (2022)
- SingHealth Publish! Award (2021)
- 2nd Mekie Book Prize (2015)
- Dean’s List (AY2013/2014, AY2014/2015 for MBBS)
View More +
Publications
- Lee, A. Y., Chen, K., Cheng, C. W., Ho, H. S., Yuen, J. S., Ngo, N. T., . . . Tay, K. J. (2023). Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy. World Journal of Urology, 41(8), 2265-2271.
- Chow, K. M., So, W. Z., Lee, H. J., Lee, A., Yap, D. W. T., Takwoingi, Y., . . . Lam, W. (2023). Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for initial staging of intermediate-to high-risk prostate cancer: a systematic review and meta-analysis. European urology, 84(1), 36-48.
- Lee, A. Y., Chen, K., Tan, Y. G., Lee, H. J., Shutchaidat, V., Fook-Chong, S., . . . Ngo, N. T. (2022). Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—Implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer and Prostatic Diseases, 25(4), 720-726.
- Lee, H. J., Lee, A., Yang, X. Y., Law, Y. M., Huang, H. H., Lau, W. K., . . . Yuen, J. S. (2021). External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer. Paper presented at the Urologic Oncology: Seminars and Original Investigations.
- Lee, A. Y., Yang, X. Y., Lee, H. J., Law, Y. M., Huang, H. H., Sim, A. S., . . . Ho, H. S. (2021). Limitations of overlapping cores in systematic and MRI-US fusion biopsy. Paper presented at the Urologic Oncology: Seminars and Original Investigations.
- Lee, A. Y., Chen, K., Law, Y. M., Ho, H. S., Cheng, C. W., Yuen, J. S., & Tay, K. J. (2021). Robot-assisted magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy. Urology, 155, 46.
- Yang, X., Lee, A. Y., Law, Y. M., Sim, A. S. P., Tay, K. J., Lau, W. K. O., . . . Chen, K. (2020). Stereotactic robot-assisted transperineal prostate biopsy under local anaesthesia and sedation: moving robotic biopsy from operating theatre to clinic. Journal of Robotic Surgery, 14, 767-772.
- Lee, H. J., Lee, A., Tan, D., Du, J., Wang, Y., Tang, P. Y., & Sim, A. S. P. (2020). Cutaneous metastasis of renal cell carcinoma. The Lancet Oncology, 21(5), e292.
- Lee, A. Y., Yang, X. Y., Lee, H. J., Law, Y. M., Huang, H. H., Lau, W. K., . . . Cheng, C. W. (2020). Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy. BJU international, 126(5), 568-576.
- Lee, A., Lee, H. J., Huang, H. H., Tay, K. J., Lee, L. S., Sim, S. P. A., . . . Chen, K. (2020). Prognostic significance of inflammation-associated blood cell markers in nonmetastatic clear cell renal cell carcinoma. Clinical Genitourinary Cancer, 18(4), 304-313.
- Lee, H. J., Lee, A., Huang, H. H., & Lau, W. K. O. (2019). External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population. Paper presented at the Urologic Oncology: Seminars and Original Investigations.
- Lee, A., Lee, H. J., Huang, H. H., Ho, H., & Chen, K. (2019). Low‐risk non‐muscle‐invasive bladder cancer: Further prognostic stratification into the “very‐low‐risk” group based on tumor size. International Journal of Urology, 26(4), 481-486.
- Chen, K., Lee, A., Huang, H. H., Tay, K. J., Sim, A., Lee, L. S., . . . Yuen, J. S. P. (2019). Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively‐maintained database. International Journal of Urology, 26(4), 465-474.
- Lee, H. J., Lee, A., Huang, H. H., & Lau, W. K. O. (2018). Primary androgen deprivation therapy as monotherapy in unfavourable intermediate-and high-risk localised prostate cancer: a Singaporean single-centre perspective. International Urology and Nephrology, 50, 665-673.
- Lee, A., Lim, J., Gao, X., Liu, L., & Chia, S. J. (2017). A nomogram for prediction of prostate cancer on multi‐core biopsy using age, serum prostate‐specific antigen, prostate volume and digital rectal examination in Singapore. Asia‐Pacific Journal of Clinical Oncology, 13(5), e348-e355.
- Lee, A., Lee, H. J., & Foo, K. T. (2017). Can men with prostates sized 80 mL or larger be managed conservatively? Investigative and Clinical Urology, 58(5), 359-364.
- Ong, W., Lee, A., Tan, W. B., & Lomanto, D. (2016). Long-term results of a randomized controlled trial of T2 versus T2–T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis. Surgical endoscopy, 30, 1219-1225.
- Lee, A., Lee, H. J., Lim, K. B., Huang, H. H., Ho, H., & Foo, K. T. (2016). Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow? Asian Journal of Urology, 3(1), 39-43.
- Lee, A., & Chia, S. J. (2015). Prostate cancer detection: The impact of obesity on Asian men. Paper presented at the Urologic Oncology: Seminars and Original Investigations.
- Lee, A., & Chia, S. J. (2015). Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination. Asian Journal of Urology, 2(4), 187-193.
View More +
